stars 1 stars 2 stars 3

PlenSat is an early stage biomedical device startup pursuing its patented technology for the treatment of obesity. PlenSat ‘Digestible Balloons” are a unique approach to achieving Bariatric effects to treat obesity without invasive techniques such as surgery, laparoscopy or endoscopy. Digestible Balloons, produced from food grade materials, promise the simplicity of pharmaceutical dosage with the weight loss profile of Bariatric techniques. PlenSat’s technology involves the production of easily ingestible capsules that are self-inflating in the acidic environment within the stomach. The expanded capsule, a “Digestible Balloon”, is sized such that once inflated it will not pass beyond the stomach until time and abrasive wear breaks it down. It is anticipated, based upon our pre-clinical and initial animal studies, that the Digestible Balloon will have a lifetime of between 7 and 30 days within the stomach. The Digestible Balloon is designed to be ultimately digested in the intestine after mechanical breakdown in the stomach.

PlenSat, Inc. Questions

The PlenSat, Inc. annual revenue was $2 million in 2026.

Houston Voss is the President of PlenSat, Inc..

1 people are employed at PlenSat, Inc..

PlenSat, Inc. is based in San Clemente, California.

The NAICS codes for PlenSat, Inc. are [33, 339].

The SIC codes for PlenSat, Inc. are [384, 38].

Top PlenSat, Inc. Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users